Developing effective treatments for pancreatic cancer requires a deep understanding of its biology. By identifying the unique features of this disease, we can discover ways to leverage its vulnerabilities and develop curative therapies. Through our preclinical science program, we focus on investigating the most critical and unique aspects of pancreatic cancer biology, with the goal of turning this knowledge into targeted treatments.
Lustgarten-funded pre-clinical science programs include: